Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Rhythm Pharmaceuticals Inc
SWB:1RV
Rhythm Pharmaceuticals Inc
SWB:1RV
Price:
92
EUR
2.79%
Market Closed
Market Cap:
€1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Rhythm Pharmaceuticals Inc
SWB:1RV
|
US |
|
I
|
inTest Corp
AMEX:INTT
|
US |
|
G
|
Grupa Kety SA
WSE:KTY
|
PL |
|
E
|
Eutelsat Communications SA
DUS:E3B
|
FR |
Wall St Price Targets
1RV Price Forecast
Based on 18 analysts
Based on 18 analysts
+41% Upside
from
€92
today
Rhythm Pharmaceuticals Inc (1RV)’s 12-month stock price forecast through August 2027 has a consensus target of €129.99, implying 41% upside. The forecast is based on price targets from 18 Wall Street analysts.
1RV Analyst Rating
No ratings yet
No ratings yet
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1RV's stock price target?
Price Target
129.99
EUR
129.99
EUR
According to Wall Street analysts, the average 1-year price target for 1RV is 129.99 EUR with a low forecast of 108.02 EUR and a high forecast of 149.72 EUR.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%
51%
The compound annual growth rate for Gross Profit over the next 6 years is 51%.
